Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 162

1.

Cholesterol lowering and stroke: no longer room for pleiotropic effects of statins - confirmation from PCSK9 inhibitor studies.

Salvatore T, Morganti R, Marchioli R, De Caterina R.

Am J Med. 2019 Jul 10. pii: S0002-9343(19)30564-9. doi: 10.1016/j.amjmed.2019.06.029. [Epub ahead of print]

PMID:
31301293
2.

IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study.

Maffei S, Cugusi L, Meloni A, Deidda M, Colasante E, Marchioli R, Surico N, Mercuro G; Working Group of Gender Cardiovascular Disease of the Italian Society of Cardiology (SIC), Italian Society of Obstetrics, Gynecology (SIGO).

J Cardiovasc Med (Hagerstown). 2019 May;20(5):278-283. doi: 10.2459/JCM.0000000000000761.

PMID:
30664071
3.

Modes of death and prognostic outliers in chronic heart failure.

Canepa M, Ameri P, Lucci D, Nicolosi GL, Marchioli R, Porcu M, Tognoni G, Franzosi MG, Latini R, Maseri A, Tavazzi L, Maggioni AP; GISSI-HF Investigators.

Am Heart J. 2019 Feb;208:100-109. doi: 10.1016/j.ahj.2018.11.009. Epub 2018 Nov 24.

PMID:
30580128
4.

Fish Oil and Perioperative Bleeding.

Akintoye E, Sethi P, Harris WS, Thompson PA, Marchioli R, Tavazzi L, Latini R, Pretorius M, Brown NJ, Libby P, Mozaffarian D.

Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e004584. doi: 10.1161/CIRCOUTCOMES.118.004584.

PMID:
30571332
5.

Fish Oil Supplementation Does Not Affect Cognitive Outcomes in Cardiac Surgery Patients in the Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA) Trial.

Jackson JC, Mozaffarian D, Graves AJ, Brown NJ, Marchioli R, Kiehl AL, Ely EW.

J Nutr. 2018 Mar 1;148(3):472-479. doi: 10.1093/jn/nxx002.

6.

Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial.

Mantovani A, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI-HF Investigators.

Metabolism. 2018 Jun;83:205-215. doi: 10.1016/j.metabol.2018.02.007. Epub 2018 Mar 29.

PMID:
29477817
7.

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.

Aung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, Geleijnse JM, Rauch B, Ness A, Galan P, Chew EY, Bosch J, Collins R, Lewington S, Armitage J, Clarke R; Omega-3 Treatment Trialists’ Collaboration.

JAMA Cardiol. 2018 Mar 1;3(3):225-234. doi: 10.1001/jamacardio.2017.5205.

8.

Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery.

Akintoye E, Sellke F, Marchioli R, Tavazzi L, Mozaffarian D.

J Thorac Cardiovasc Surg. 2018 Jan;155(1):242-251.e10. doi: 10.1016/j.jtcvs.2017.07.063. Epub 2017 Aug 16.

PMID:
28890081
9.

Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.

Dauriz M, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI‐HF Investigators.

J Am Heart Assoc. 2017 Jul 5;6(7). pii: e005156. doi: 10.1161/JAHA.116.005156.

10.

Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial.

Rossi A, Inciardi RM, Rossi A, Temporelli PL, Lucci D, Gonzini L, Marchioli R, Nicolosi GL, Tavazzi L; GISSI-HF Investigators.

Pulm Pharmacol Ther. 2017 Jun;44:16-23. doi: 10.1016/j.pupt.2017.03.001. Epub 2017 Mar 3.

PMID:
28263812
11.

A low plasma 1,25(OH)2 vitamin D/PTH (1-84) ratio predicts worsening of renal function in patients with chronic heart failure.

Masson S, Barlera S, Colotta F, Magnoli M, Bonelli F, Moro M, Marchioli R, Tavazzi L, Tognoni G, Latini R.

Int J Cardiol. 2016 Dec 1;224:220-225. doi: 10.1016/j.ijcard.2016.09.014. Epub 2016 Sep 10.

PMID:
27657477
12.

Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Heart Failure trial.

Harris WS, Masson S, Barlera S, Milani V, Pileggi S, Franzosi MG, Marchioli R, Tognoni G, Tavazzi L, Latini R; GISSI-HF Investigators.

Nutr Res. 2016 Sep;36(9):989-994. doi: 10.1016/j.nutres.2016.06.012. Epub 2016 Jun 28.

PMID:
27632919
13.

Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial.

Canepa M, Temporelli PL, Rossi A, Rossi A, Gonzini L, Nicolosi GL, Staszewsky L, Marchioli R, Maggioni AP, Tavazzi L; GISSI-HF Investigators.

Cardiology. 2017;136(2):128-137. doi: 10.1159/000448166. Epub 2016 Sep 8.

PMID:
27618363
14.

All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT.

De Caterina R, Salvatore T, Marchioli R.

Data Brief. 2016 Apr 27;7:1541-50. doi: 10.1016/j.dib.2016.04.059. eCollection 2016 Jun.

15.

Cholesterol-lowering interventions and stroke: Insights from IMPROVE-IT.

De Caterina R, Salvatore T, Marchioli R.

Atherosclerosis. 2016 May;248:216-8. doi: 10.1016/j.atherosclerosis.2016.03.024. Epub 2016 Mar 18.

PMID:
27035113
16.

Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial.

Wu JH, Marchioli R, Silletta MG, Masson S, Sellke FW, Libby P, Milne GL, Brown NJ, Lombardi F, Damiano RJ Jr, Marsala J, Rinaldi M, Domenech A, Simon C, Tavazzi L, Mozaffarian D.

J Am Heart Assoc. 2015 May 20;4(5). pii: e001886. doi: 10.1161/JAHA.115.001886.

17.

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.

Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, Rahimi K, Colhoun HM, Waters DD, LaRosa JC, Amarenco P, Pedersen TR, Tikkanen MJ, Koren MJ, Poulter NR, Sever PS, Ridker PM, MacFadyen JG, Solomon SD, Davis BR, Simpson LM, Nakamura H, Mizuno K, Marfisi RM, Marchioli R, Tognoni G, Athyros VG, Ray KK, Gotto AM, Clearfield MB, Downs JR, McMurray JJ.

Eur Heart J. 2015 Jun 21;36(24):1536-46. doi: 10.1093/eurheartj/ehv072. Epub 2015 Mar 23. Review.

18.

Phase I dose escalation study of lestaurtinib in patients with myelofibrosis.

Hexner EO, Mascarenhas J, Prchal J, Roboz GJ, Baer MR, Ritchie EK, Leibowitz D, Demakos EP, Miller C, Siuty J, Kleczko J, Price L, Jeschke G, Weinberg R, Basu T, Pahl HL, Orazi A, Najfeld V, Marchioli R, Goldberg JD, Silverman LR, Hoffman R.

Leuk Lymphoma. 2015;56(9):2543-51. doi: 10.3109/10428194.2014.1001986. Epub 2015 Feb 20.

19.

Circulating cardiac biomarkers and postoperative atrial fibrillation in the OPERA trial.

Masson S, Wu JH, Simon C, Barlera S, Marchioli R, Mariani J, Macchia A, Lombardi F, Vago T, Aleksova A, Dreas L, Favaloro RR, Hershson AR, Puskas JD, Dozza L, Silletta MG, Tognoni G, Mozaffarian D, Latini R; OPERA Investigators.

Eur J Clin Invest. 2015 Feb;45(2):170-8. doi: 10.1111/eci.12393. Epub 2015 Jan 7.

20.

Prognostic impact of metabolic syndrome in patients with chronic heart failure: data from GISSI-HF trial.

Perrone-Filardi P, Savarese G, Scarano M, Cavazzina R, Trimarco B, Minneci S, Maggioni AP, Tavazzi L, Tognoni G, Marchioli R.

Int J Cardiol. 2015 Jan 15;178:85-90. doi: 10.1016/j.ijcard.2014.10.094. Epub 2014 Oct 23.

PMID:
25464226

Supplemental Content

Loading ...
Support Center